Replimune Group REPL2.15%increase; up pointing triangle said Friday it has reached an agreement with the Food and Drug Administration on a path to resubmit its application for its experimental ...

Replimune said it plans to resubmit its melanoma drug for approval following two earlier rejections. The move follows the departure of Food and Drug Administration Commissioner Marty Makary. Replimune ...

A Woburn biotechnology company is set to lay off dozens of Massachusetts employees after federal regulators rejected its lead cancer treatment for the second time. According to a Worker Adjustment and ...

Stock futures cautious on Monday as investors reacted to a breakdown in peace talks between the U.S. and Iran over the weekend. Tensions spiked after President Donald Trump threatened a military ...

News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...

April 10 (Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Replimune's (REPL.O), opens new tab drug for advanced skin cancer, citing insufficient ‌data from studies, ...

A SYSTEM DESIGNED to predict the most likely next word in a sentence can also write good computer code, offer strategic advice and respond with remarkable empathy to human problems. We don’t fully ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

The JavaScript innovation train is really picking up momentum lately, driven—as always—by the creativity of the JavaScript developer community. The emerging local-first SQL datastores crystalize ideas ...

Google has removed a whole section from its JavaScript SEO documentation because it was outdated and Google says loading content with JavaScript does not make it hard for Google Search. Google wrote ...